PDX-Derived Gastric Cancer Organoid Model

Gastric cancer remains one of the most challenging cancers to treat, and the development of effective therapies has been slow. To accelerate research, gastric cancer PDX models (patient-derived xenograft models) have become a crucial tool for preclinical studies. These models, which involve implanting human gastric cancer tissue into immunocompromised mice, provide a more accurate representation of human tumors, making them invaluable for testing new drug candidates and understanding cancer biology. Researchers rely on gastric cancer PDX models to identify potential biomarkers, study tumor heterogeneity, and evaluate treatment responses in a way that traditional cell line-based models cannot replicate.

0 Replies:

Leave a Reply

Your email address will not be published. Required fields are marked *